Stay updated with breaking news from Nasdaq Cers. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com assumed coverage on shares of Cerus (NASDAQ:CERS – Get Rating) in a note issued to investors on Thursday. The firm set a “hold” rating on the biotechnology company’s stock. Separately, Zacks Investment Research downgraded Cerus from a “buy” rating to a “hold” rating in a research report on Friday, February 25th. CERS stock traded […]
Cerus Co. (NASDAQ:CERS – Get Rating) was the recipient of unusually large options trading activity on Tuesday. Investors bought 2,772 call options on the company. This represents an increase of approximately 1,095% compared to the typical volume of 232 call options. Separately, Zacks Investment Research lowered shares of Cerus from a “buy” rating to a […]
Cerus Co. (NASDAQ:CERS – Get Rating) SVP Carol Moore sold 28,513 shares of the company’s stock in a transaction that occurred on Monday, March 14th. The stock was sold at an average price of $5.04, for a total value of $143,705.52. The transaction was disclosed in a legal filing with the SEC, which is accessible […]
UBS Group AG grew its holdings in shares of Cerus Co. (NASDAQ:CERS – Get Rating) by 1,377.4% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 615,050 shares of the biotechnology company’s stock after acquiring an additional 573,420 shares during the […]